Avian influenza viruses occasionally infect and adapt to mammals, including humans. 12
Introduction 25
Influenza A viruses continuously circulate in their natural reservoir of wild aquatic and 26 sea birds. Occasionally, avian influenza viruses infect mammalian hosts, but these zoonotic 27 viruses have to adapt for efficient replication and further transmission. This limits the 28 emergence of novel endemic strains. Avian-origin, mammalian-adapted influenza viruses 29 have been isolated from a range of mammalian species including humans, swine, horses, 30 dogs, seals, and bats (1-6).
One mammalian influenza host of significance are swine, which have been described 32 as susceptible to viruses of both human-and avian-origin (6). It has been hypothesised that 33 swine act as 'mixing vessels', allowing efficient gene transfer between avian-and mammalian-34 adapted viruses. This leads to reassortants, which are able to replicate in humans, but to 35 which populations have no protective antibody responses, as best illustrated by the 2009 36 H1N1 pandemic (pH1N1) (7) . The ability of pigs to act as 'mixing vessels' has generally been 37 attributed to the diversity of sialic acids, the receptors for influenza, found in pigs that would 38 enable co-infection of a single host by diverse influenza strains (8, 9) . The husbandry of swine 39 has also been hypothesised to play a role in this 'mixing vessel' trait; swine are often exposed 40 to wild birds and it is likely their environments are often contaminated with wild bird 41 droppings containing avian influenza viruses. 42
For an avian-origin influenza virus to efficiently infect and transmit between mammals 43 several host barriers must be overcome. One major barrier is the weak activity of avian 44 influenza virus polymerases in the mammalian cell. The acidic (leucine-rich) nuclear 45 phosphoproteins of 32 kilodaltons (ANP32) proteins are key host factors responsible for the 46 restricted polymerase activity of avian influenza viruses in mammalian cells (10). ANP32 proteins possess an N-terminal domain composed of five leucine rich repeats (LRRs) and a C-only express the shorter forms of ANP32 proteins which do not efficiently support avian 56 polymerase unless the virus acquires adaptive mutations, particularly in the PB2 polymerase 57 subunit, such as E627K (10). A further difference between the ANP32 proteins of different 58 species is the level of redundancy in their ability to support influenza polymerase. In humans, 59 two paralogues -ANP32A and ANP32B -are essential but redundant influenza polymerase 60 cofactors (14, 15) . In birds, only a single family member -ANP32A -supports influenza virus 61 polymerase activity, as avian ANP32B proteins are not orthologous to mammalian ANP32B 62 (11, 15, 16) . In mice, only ANP32B can support influenza A polymerase activity (14, 15) . 63
Neither avian nor mammalian ANP32E proteins have been shown to support influenza 64 polymerase activity (14-16). 65
In this study, we investigated the ability of a variety of mammalian ANP32 proteins to 66 support influenza virus polymerases derived from viruses isolated from a range of hosts. We 67 find differences in pro-viral efficiency that do not always coincide with the natural virus-host 68 relationship: for example, human ANP32B is better able to support bat influenza polymerases 69 than either bat ANP32 protein. Conversely, we describe evidence of human ANP32 adaptation 70 early during the emergence of the pH1N1 virus from pigs, and find that swine ANP32A is the 71 most potent pro-viral mammalian ANP32 protein tested, capable even of modestly 72 supporting avian virus polymerases. This can be attributed to amino acid differences in the 73 LRR4 and central domains that enhance the interaction between swine ANP32A and the 74 influenza polymerase complex, suggesting a mechanism for this super pro-viral activity and 75 giving support to the special status as potential 'mixing vessels' of swine in influenza 76 evolution.
Results

78
Mammals naturally susceptible to influenza have two pro-viral ANP32 proteins.
79
To investigate the ability of different mammalian ANP32A and ANP32B proteins to 80 support influenza virus polymerase activity, several mammalian-origin influenza virus 81 polymerase constellations were tested using an ANP32 reconstitution minigenome assay. A 82 previously described human cell line with both ANP32A and ANP32B ablated (eHAP dKO) was 83 transfected with ANP32A or ANP32B expressing plasmids from chicken, human, swine, horse, 84 dog, seal or bat, as well as the minimal set of influenza polymerase expression plasmids for 85 PB2, PB1, PA and nucleoprotein (NP), to drive amplification and expression of a firefly-86 luciferase viral-like reporter RNA and a Renilla-luciferase expression plasmid as a transfection 87 control. 88
showed that a single substitution in the PA subunit of the polymerase, N321K, contributed to 124 increased polymerase activity of third-wave pH1N1 viruses in human cells (18). We 125 hypothesised that this PA mutation might function by improving support for the emerging 126 virus polymerase by the human ANP32 proteins. 127
We performed minigenome assays with a first-wave pandemic virus, 128
E195), and a third-wave pandemic virus 129 A/England/687/2010(pH1N1; E687), which differ in PA at position 321. As shown before, PA 130 swine ANP32A and the other mammalian orthologues. Using reciprocal mutant ANP32A 147 proteins, the identity of amino acid position 156, naturally a serine in swine ANP32A but a 148 proline in most other mammalian ANP32A proteins, was shown to have a major, reciprocal 149 influence on activity (Fig. 4a ). The amino acid at position 106 contributed to a lesser degree, 150 with swine-like valine enhancing pro-viral activity over human-like isoleucine. Position 228, 151 localised nearby the C-terminal nuclear localisation signal of ANP32A, had no appreciable 152 impact. In the background of human ANP32A, I106V generally gave between a 1.5-and 6-fold 153 increase in polymerase activity while P156S gave between a 3-and 16-fold boost, depending 154 on the polymerase constellation tested. The combined 106/156 mutant showed an additive 155 effect implying these two residues are, together, responsible for the enhanced pro-viral 156 activity of swine ANP32A (Fig. 4a ). None of the mutations affected expression levels ( Fig. 4b ).
To assess the strength of interaction between swine ANP32A protein and influenza 170 polymerase, we used a split-luciferase assay, where the two halves of Gaussia luciferase are 171 fused onto PB1 and ANP32 protein (11, 20) . Swine ANP32A interacted strongly with both 172 human-origin -E195 (pH1N1 2009) -and avian-origin -A/turkey/England/50-92/1992(H5N1) 173 -influenza polymerases, although not as strongly as chicken ANP32A (Fig. 5a ). Furthermore, 174 the two residues identified as being responsible for strong pro-viral activity of swine ANP32A, 175 at positions 106 and 156, conferred this stronger polymerase binding, implying the mode of 176 action of these mutations is through enhancing ANP32-polymerase interactions ( Fig. 5a ). It 177 was also shown that N129I, the substitution naturally identified in chicken ANP32B and 178 previously shown to abolish binding and activity in chicken and human ANP32 proteins (11, 179 15), showed a similar phenotype in swine ANP32A, abolishing detectable binding and activity 180 ( Fig. 5a,b ). The ablations of the pro-viral activity of swine ANP32A and ANP32B by the 181 substitution N129I was not explained by reductions in expression of these mutant proteins 182 ( Fig. 5b,c) . 183
Estimating the pro-viral activity of other mammalian species ANP32A proteins 184 Based on the molecular markers described in this study it is possible to survey ANP32A 185 proteins from all mammals to predict which other species may have highly influenza 186 polymerase supportive proteins and therefore potential to act as mixing vessels for 187 reassortment between avian and mammalian-adapted influenza viruses. 188
Very few mammals share the pro-viral marker, 156S, and the few that do mostly 189 constitute species not yet described as hosts for influenza viruses (Fig. 5d ). A notable 190 exception is the pika which, in a similar manner to pigs, appears to be highly susceptible to avian influenza viruses with minimal mammalian adaptation (21-23). Pigs are currently the 192 only known mammalian species that contain the secondary, minor pro-viral maker 106V. 193 194 In this study we describe the ability of different mammalian ANP32A and ANP32B 195 proteins to support activity of influenza virus polymerases isolated from a variety of hosts. 196
Discussion
We found that swine ANP32A, uniquely among the ANP32 proteins, supports avian influenza 197 virus polymerase activity. Swine ANP32A does not harbour the avian-specific 33 amino acid 198 duplication that enables the strong interaction and efficient support of polymerase activity of 199 avian-origin viruses by avian ANP32A proteins. Thus, avian influenza viruses are restricted for 200 replication in swine as we have previously shown, and mammalian-adapting mutations 201 enhance their polymerase activity in pig cells (24). Nonetheless, this level of pro-viral activity 202 associated with swine ANP32A, albeit weak compared to avian ANP32As, may contribute to 203 the role of swine as mixing vessels: non-adapted avian influenza viruses that infect pigs could 204 replicate sufficiently to accumulate further mutations that allow for more efficient 205 mammalian adaptation and/or reassortment, enabling virus to either become endemic in 206 swine or to jump into other mammals, including humans. 207
We map this strongly pro-viral polymerase phenotype to a pair of mutations which 208 allow swine ANP32A to bind more strongly to influenza virus polymerase, potentially 209 explaining the mechanism behind its super pro-viral activity. These residues are only found in 210 a handful of other mammals including wild pigs and pika. It is conceivable these residues are 211 located at a binding interface between polymerase and ANP32, but resolution of the structure 212 of the host:virus complex will be required to confirm this hypothesis.
It has long been speculated that swine play a role as 'mixing vessels', by acting as host 214 to both human-and avian-origin influenza viruses. This trait may be partially attributed to 215 receptor patterns in swine allowing viruses that bind to both α2,3 linked (i.e. avian-like 216 viruses) and α2,6 linked sialic acid (i.e. human-like) to replicate alongside each other (8, 9) . 217
However, replication of the avian-origin influenza virus genomes inside infected cells is also 218 required to enhance the opportunity for further adaptation or reassortment. We previously 219 developed a minigenome assay for assessing polymerase activity in swine cells and showed 220 that avian virus polymerases were restricted and that restriction could be overcome by typical 221 mutations known to adapt polymerase to human cells (24). Taken together the ability to enter 222 swine cells without receptor switching changes in the haemagglutinin gene, along with a 223 greater mutation landscape afforded in swine cells by the partially supportive pro-viral 224 function of swine ANP32A may have an additive effect to allow swine to act an intermediate 225 host for influenza viruses to adapt to mammals. Furthermore, our work implies other 226 mammals, such as the pika, could play a similar role which is of particular interest due to the 227 pika's natural habitat often overlapping with that of wild birds and its (somewhat swine-like) 228 distribution of both α2,3 and α2,6-linked sialic acid receptors (25). 229
Upon crossing into humans from swine, it is likely that viruses would be under 230 selective pressure to adapt to human pro-viral factors, such as the ANP32 proteins. We use 231 the example of a pair of first-and third-wave pandemic H1N1 influenza viruses isolated from 232 clinical cases in 2009 and 2010 (18). The polymerase constellation of the 2009 pH1N1 virus 233 contains PB2 and PA gene segments donated from avian sources to a swine virus in a triple 234 reassortant constellation in the mid-1990s, then passed onto humans in 2009 (17). Although 235 the first-wave viruses, derived directly from swine, can clearly replicate and transmit between support of the viral polymerase by human ANP32 proteins -our data suggests this is a direct 238 adaptation to the less supportive human ANP32 proteins. This again illustrates how swine 239 have acted as a 'halfway house' for the step-wise adaptation of genes originating in avian 240 influenza viruses that have eventually become humanised. 241
Also of note, we show here that as for the human orthologues, the ANP32A and B 242 proteins of swine (as well as all other mammals tested here) are fairly redundant in their pro 243 influenza activity to support the viral polymerase. We further show that the substitution 244 N129I is able to partially or fully ablate the pro-viral activity of both swine ANP32A and 245 ANP32B. We suggest that the introduction of this substitution in both swine ANP32A and 246 ANP32B by genome editing would be a feasible basis generating influenza resistant, or 247 resilient, pigs, in a similar manner to that demonstrated for porcine respiratory and 248 reproductive syndrome virus resistant pigs, and proposed for influenza resistant, or resilient, 249 chickens (11, 26). 250
To conclude, we hypothesise that the superior pro-viral function of swine ANP32A for 251 supporting influenza replication may play a role in both the ability of swine to host avian 252 influenza viruses, but also upon the potential evolutionary ecology of swine influenza viruses. 253
This, in turn, may influence the ability of different swine influenza viruses to act as zoonotic 254 hosts or as potential pandemic viruses. Split luciferase assays were undertaken in 293Ts seeded in 24 well plates. 30ng each 318 of PB2, PA, and PB1, with the N-terminus of Gaussia Luciferase (Gluc1) tagged to its C-319 terminus after a GGSGG linker, were co-transfected using lipofectamine 3000 along with 320 ANP32A, tagged with the C-terminus of Gaussia Luciferase (Gluc2) on its C-terminus (after a 321
GGSGG linker). 24 hours later cells were lysed in 100µl of Renilla lysis buffer (Promega) and 322
Gaussia activity was measured using a Renilla luciferase kit (Promega) on a FLUOstar Omega 323 plate reader (BMG Labtech). Normalised luminescence ratios (NLR) were calculated by 324 dividing the values of the tagged PB1 and ANP32 wells by the sum of the control wells which 325 contained 1) untagged PB1 and free Gluc1 and 2) untagged ANP32A and free Gluc2 as 
